Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 30, 2019
Acceleron and Fulcrum have entered into a collaboration and license agreement to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space.
read more
Monday, December 30, 2019
Dr. Reddy’s announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® Injection.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more
Monday, December 30, 2019
NPXe Limited has filed a voluntary petition to reorganize under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
read more
Monday, December 30, 2019
Mavidon is voluntarily recalling all lots of products manufactured at our facility including LemonPrep®, PediaPrep® and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions, Collodion removers due to contamination with Burkholderia...
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more
Monday, December 23, 2019
Compounded drugs can serve an important role in meeting patients’ medical needs that cannot be met by an FDA-approved drug.
read more
Monday, December 23, 2019
Charles River Laboratories announced a definitive agreement to acquire HemaCare for approximately $380 million in cash.
read more
Monday, December 23, 2019
BC Platforms has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™.
read more
Monday, December 23, 2019
Fortress Biotech announced Baergic Bio entered into an agreement with AstraZeneca for AZD7325, a novel a2/3–subtype-selective GABA A PAM, as well as an agreement with Cincinnati Children’s Hospital Medical Center to advance clinical development in ...
read more
Monday, December 23, 2019
Lacutamab will not be administered to new patients in the TELLOMAK trial until additional feedback is received from the respective regulatory agencies overseeing our clinical trial.
read more
Monday, December 23, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
read more
Monday, December 23, 2019
Alcami announced plans to expand the company’s current operations in Charleston County. The $17 million investment is expected to create 30 new jobs.
read more
Monday, December 23, 2019
PerkinElmer has announced a collaboration with Emerald Scientific, a cannabis and hemp lab technology provider.
read more
Monday, December 23, 2019
G-CON Manufacturing announced the expansion of its manufacturing facility for POD superstructures in College Station, TX.
read more